The FDA’s recent decisions regarding compound GLP-1s have had a significant impact on the obesity drug market, particularly for pharma…
Trending
- The Mind-Blowing Trick To Picking the Sweetest Blueberries Every Time
- Can anything threaten Novo and Lilly’s obesity market dominance?
- Computational analysis links blood RNA patterns to ALS diagnosis and prognosis
- New Medicare program could dramatically improve affordability for cancer drugs—if patients enroll
- Six NIH institutes get new acting directors
- 6 Kitchen Items You Should Replace More Often
- Large study of chronic disease in rural areas faces loss of funding
- 2025 NFL Draft Hopeful Dillon Gabriel Leads Youth Football Concussion Safety Effort